Previous studies investigating the mechanism(s) of MAPK or AKT inhibitor-induced cell death in NHL and HL cell lines have demonstrated the induction of different death pathways involving both caspase-dependent and caspase-independent mechanisms26, ROS generation27, and JNK activation28. The gene discussed is AKT1; the disease is non-Hodgkin lymphoma.